NuVasive faces setback over reimbursement of surgical procedure

12/1/2009 | CNBC

Aetna, Cigna and UnitedHealth Group will not pay surgeons who use NuVasive's XLIF spinal surgery after they classified the procedure as "experimental." NuVasive said it is working to reverse the health insurers' recommendation, and doctors are still receiving payments at local and regional levels.

View Full Article in:

CNBC

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
AdvaMed
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
AdvaMed
Washington DC, DC
Director, Corporate Counsel
Regeneron
Tarrytown, NY